BDX - Utang jangka cendhak marang modal Becton Dickinson

Becton Dickinson & Co (BDX) generates revenue from global supplies of consumables and diagnostic systems. The short-term debt to equity trend helps assess the current debt load, with the 0.13 level serving as a critical benchmark. The business relies on laboratory automation and robotic medication dispensing. However, strict government regulatory oversight and the risk of product recalls could reduce overall profitability.

The analyst assesses the credit risks of Becton Dickinson & Co (BDX) through the ratio of short-term liabilities to equity. The company's dominance in the medical consumables segment and stringent FDA barriers ensure a stable cash flow to service current loans. The company's short-term leverage history visualizes the share of "fast" loans within the financing structure relative to shareholder value. Low indicator values confirm financial autonomy, while moderate growth may suggest profitability optimization.